Sensco announced on the 8th that it plans to expand sales of ‘Timemachine Lift Thread’ throughout Europe by 2025.
Previously, Sensco signed an exclusive supply contract for the lifting thread ‘Timemachine Lift Thread’ with an Iranian cosmetic surgery product specialist distribution company in 2021, and has successfully entered the Iranian market through various exhibitions, academic conferences, and webinars. In addition, we have built and strengthened our sales base in Japan, Spain, Saudi Arabia, Mexico, and Switzerland.
In the international face lifting market, lifting threads are attracting attention because they relatively simply improve skin sagging and wrinkles using meltable threads without incising the skin.
Among these, the ‘Anchoring dual lift cog’ of Sensco’s Timemachine Lift Thread has the feature of inserting two lifting threads with different characteristics with a single shot, unlike existing lifting threads. have Not only can a stronger lifting effect be expected through the differentiated lifting thread cutting method, but it also has perfect fixation (double fixation) by additionally manufacturing a specially designed ending force part.
‘Timemachine Lift Thread’s PDO (Polydioxanone) has obtained medical grade 4 from the KFDA Safety Evaluation Institute, has been internationally certified as Class III according to the European Medical Device Directive, and is manufactured in GMP, ISO13485, and CE certified facilities. It is produced under strict quality standards.
A Sensco official said, “Timemachine lifting thread, which means using lifting thread to return to a firm, youthful-looking face without wrinkles in your youth, as if you are going back to the past in a time machine, complements the shortcomings of existing lifting threads and provides lifting and fixation effects. “It is a further upgraded product,” he said. “Sensco is not satisfied with the current status quo and is developing PCL (Polycaprolactone), PLLA (Poly-L-Lactic Acid), and PLCL ((L-lactide-co- “We are also working on research and development of products made of ε-caprolactone).”